RAC 1.63% $1.81 race oncology ltd

General Comments / Chat, page-86

  1. 709 Posts.
    lightbulb Created with Sketch. 277
    Question to Daniel if I may. Perhaps for the next presentation if the answer will take too long here.

    I am interested in your thoughts re Bisantrene vs liposomal Doxorubicin. As I understand it they both have marked reduced cardio toxicity compared to standard and are both well advanced in the clinic. I would value your thoughts as to why Bisantrene may be expected to be better and why oncologists would swap one for the other on a new trial design.
    thanks
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.81
Change
-0.030(1.63%)
Mkt cap ! $307.6M
Open High Low Value Volume
$1.85 $1.94 $1.77 $230.8K 124.6K

Buyers (Bids)

No. Vol. Price($)
1 15405 $1.79
 

Sellers (Offers)

Price($) Vol. No.
$1.85 1750 1
View Market Depth
Last trade - 16.10pm 25/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.